IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils
Open Access
- 11 May 2021
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 14 (5) , 1183-1202
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Pertussis: Challenges Today and for the FuturePLOS Pathogens, 2013
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis VaccinePLOS Pathogens, 2013
- Spontaneous Eosinophilic Nasal Inflammation in a Genetically-Mutant Mouse: Comparative Study with an Allergic Inflammation ModelPLOS ONE, 2012
- Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in JapanPLOS ONE, 2012
- Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countriesProceedings Of The Royal Society B-Biological Sciences, 2010
- Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in diseaseImmunology, 2010
- Role of Neutrophils in Response toBordetella pertussisInfection in MiceInfection and Immunity, 2009
- Interleukin-17A Mediates Acquired Immunity to Pneumococcal ColonizationPLOS Pathogens, 2008
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006